Suppresses Experimental Autoimmune Expansion of Autoreactive T Cells and Deficiency Controls β

Kuchroo, Klaus Rajewsky and Marc Schmidt-SupprianBettelli, Raymond A. Sobel, Anthony Coyle, Vijay K. Bernhard Greve, Robert Weissert, Nada Hamdi, Estellehttp://www.jimmunol.org/content/179/1/179J Immunol€2007; 179:179-185; ;Referenceshttp://www.jimmunol.org/content/179/1/179.full#ref-list-1This article cites 28 articles, 13 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  N. Munshi,et al.  NF-κB as a Therapeutic Target in Multiple Myeloma* , 2002, The Journal of Biological Chemistry.

[2]  B. Hilliard,et al.  Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. , 1999, Journal of immunology.

[3]  I. Verma,et al.  IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy , 2003, Molecular and Cellular Biology.

[4]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[5]  K. Rajewsky,et al.  IκB Kinase 2 Deficiency in T Cells Leads to Defects in Priming, B Cell Help, Germinal Center Reactions, and Homeostatic Expansion1 , 2004, The Journal of Immunology.

[6]  M. Schmid,et al.  Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis , 2000, Neuroscience Letters.

[7]  H. Weiner,et al.  Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.

[8]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[9]  R. Maehr,et al.  Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Ben-nun,et al.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.

[11]  J. Seidman,et al.  Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. , 1996, Journal of immunology.

[12]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[13]  J. Adams,et al.  Novel IKK inhibitors: β-carbolines , 2003 .

[14]  B. McManus,et al.  Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway , 2005, Journal of Virology.

[15]  Jing Sun,et al.  Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. , 2002, The Journal of clinical investigation.

[16]  Charles A. Janeway,et al.  Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice , 1996, The Journal of experimental medicine.

[17]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[18]  A. Cross,et al.  B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.

[19]  R. Ransohoff,et al.  The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.

[20]  G. Courtois,et al.  Mature T cells depend on signaling through the IKK complex. , 2003, Immunity.

[21]  V. Kuchroo,et al.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.

[22]  Jürgen R. Müller,et al.  Lymphotoxin β Receptor Induces Sequential Activation of Distinct NF-κB Factors via Separate Signaling Pathways* , 2003, The Journal of Biological Chemistry.

[23]  S. Ghosh,et al.  Experimental Allergic Encephalomyelitis in the Adoptive Transfer Model of Essential Modifier-Binding Domain Peptides B k Antineuroinflammatory Effect of NF-Fung, , 2004 .

[24]  A. Mildner,et al.  Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice , 2006, Nature Immunology.

[25]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .